作者: Isabel Burghardt , Felix Tritschler , Christiane A. Opitz , Brigitte Frank , Michael Weller
DOI: 10.1016/J.BBRC.2007.01.012
关键词: Downregulation and upregulation 、 Furin 、 TGF beta receptor 2 、 Cancer research 、 Endoglin 、 Molecular biology 、 Chemistry 、 Growth inhibition 、 Transforming growth factor 、 Glioma 、 TGF alpha
摘要: Due to its immunosuppressive properties, the cytokine transforming growth factor (TGF)-beta has become a promising target in experimental treatment of human malignant gliomas. Here, we report that antifibrotic drug 5-methyl-1-phenyl-2-(1H)-pyridone (pirfenidone, PFD) elicits growth-inhibitory effects and reduces TGF-beta2 protein levels glioma cell lines. This reduction is biologically relevant since PFD inhibition TGF-beta-sensitive CCL-64 cells mediated by conditioned media cells. The downregulation TGF-beta at multiple levels. leads mRNA mature due decreased expression direct pro-protein convertase furin. In addition, matrix metalloproteinase (MMP)-11, gene furin substrate involved carcinogenesis. These data define or PFD-related agents as for cancers associated with enhanced activity.